Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F A Wiesel

Showing results (41-50 of 86) with videos related to

Pageof 9
Sort By:
European Journal of Nuclear Medicine|January 1, 1987
The Bücherer-Strecker synthesis of D- and L-(1-11C)tyrosine and the in vivo study of L-(1-11C)tyrosine in human brain using positron emission tomographyC Halldin, K O Schoeps, S Stone-Elander, et al.
Acta Psychiatrica Scandinavica|September 1, 1986
Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patientsH Nyman, H Nybäck, F A Wiesel, et al.
Acta Psychiatrica Scandinavica|December 1, 1987
Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patientsF A Wiesel, G Wik, I Sjögren, et al.
Journal of Neurochemistry|March 1, 1984
Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjectsL Hagenfeldt, L Bjerkenstedt, G Edman, et al.
Biological Mass Spectrometry|April 1, 1994
Characterization of neurotensin-like immunoreactivity in human cerebrospinal fluid by high-performance liquid chromatography combined with mass spectrometryU Eriksson, P Andrén, J Silberring, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1985
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsL Bjerkenstedt, G Edman, L Hagenfeldt, et al.
Acta Psychiatrica Scandinavica|August 1, 1986
Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatmentG Wik, F A Wiesel, P Eneroth, et al.
Neuropsychobiology|January 1, 1982
Failure to detect immunologic stigmata in schizophreniaA Ehrnst, F A Wiesel, L Bjerkenstedt, et al.
Neuropsychobiology|January 1, 1985
Scale construction of the Swedish CPRS versionN von Luckner, B Woggon, M Asberg, et al.
Psychiatry Research|August 1, 1983
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteersH Nybäck, B M Berggren, T Hindmarsh, et al.
Pageof 9

Showing results (41-50 of 86) with videos related to

Sort By:
Pageof 9
European Journal of Nuclear Medicine|January 1, 1987
The Bücherer-Strecker synthesis of D- and L-(1-11C)tyrosine and the in vivo study of L-(1-11C)tyrosine in human brain using positron emission tomographyC Halldin, K O Schoeps, S Stone-Elander, et al.
Acta Psychiatrica Scandinavica|September 1, 1986
Neuropsychological test performance, brain morphological measures and CSF monoamine metabolites in schizophrenic patientsH Nyman, H Nybäck, F A Wiesel, et al.
Acta Psychiatrica Scandinavica|December 1, 1987
Altered relationships between metabolic rates of glucose in brain regions of schizophrenic patientsF A Wiesel, G Wik, I Sjögren, et al.
Journal of Neurochemistry|March 1, 1984
Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjectsL Hagenfeldt, L Bjerkenstedt, G Edman, et al.
Biological Mass Spectrometry|April 1, 1994
Characterization of neurotensin-like immunoreactivity in human cerebrospinal fluid by high-performance liquid chromatography combined with mass spectrometryU Eriksson, P Andrén, J Silberring, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1985
Plasma amino acids in relation to cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy controlsL Bjerkenstedt, G Edman, L Hagenfeldt, et al.
Acta Psychiatrica Scandinavica|August 1, 1986
Dexamethasone suppression test in schizophrenic patients before and during neuroleptic treatmentG Wik, F A Wiesel, P Eneroth, et al.
Neuropsychobiology|January 1, 1982
Failure to detect immunologic stigmata in schizophreniaA Ehrnst, F A Wiesel, L Bjerkenstedt, et al.
Neuropsychobiology|January 1, 1985
Scale construction of the Swedish CPRS versionN von Luckner, B Woggon, M Asberg, et al.
Psychiatry Research|August 1, 1983
Cerebroventricular size and cerebrospinal fluid monoamine metabolites in schizophrenic patients and healthy volunteersH Nybäck, B M Berggren, T Hindmarsh, et al.
Pageof 9